Search

Search Results
Results 151 - 160 of 450 for Active site
  • DBL Ergometrine
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about DBL Ergometrine intended for persons living in Australia.
  • DBL Aciclovir Intravenous
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about DBL Aciclovir Intravenous intended for persons living in Australia.
  • Aimovig
    Drug - 23 Aug 2023
    Consumer Medicine Information (CMI) about Aimovig intended for persons living in Australia.
  • Pergoveris solution for injection
    Drug - 29 Mar 2023
    Consumer Medicine Information (CMI) about Pergoveris solution for injection intended for persons living in Australia.
  • DBL Vancomycin
    Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about DBL Vancomycin intended for persons living in Australia.
  • Somavert
    Drug - 31 Jan 2023
    Consumer Medicine Information (CMI) about Somavert intended for persons living in Australia.
  • Menveo
    Drug - 23 Nov 2022
    Consumer Medicine Information (CMI) about Menveo intended for persons living in Australia.
  • Proveblue
    Drug - 27 Oct 2022
    Consumer Medicine Information (CMI) about Proveblue intended for persons living in Australia.
  • DBL Dobutamine
    Drug - 17 Aug 2022
    Consumer Medicine Information (CMI) about DBL Dobutamine intended for persons living in Australia.
  • DBL Papaverine Hydrochloride
    Drug - 23 Mar 2022
    Consumer Medicine Information (CMI) about DBL Papaverine Hydrochloride intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback